Last week, biotech was a standout performer. As of Friday morning, the SPDR S&P Biotech ETF delivered gains of 6.42% versus gains of 1.79%. Last year biotech was a significant laggard. However, in the ...
Chicago, IL – January 16, 2023 – Today, Zacks Investment Ideas feature highlights SPDR S&P Biotech ETF XBI, Catalyst Pharma Inc. CPRX, Prometheus Biosciences RXDX, Sage Therapeutics Inc SAGE and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback